Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p7
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 7/51)
Character Range: 18980–21872

and 30 tablets rosuvastatin 20 mg (as calcium) [Brand: Ezalo Composite Pack 10mg+20mg; Maximum Quantity: 2; Number of Repeats: 5]
insert:
Ezetimibe and rosuvastatin  Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)  Oral  Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg  SZ  MP NP             1  5     1
Ezetimibe and rosuvastatin  Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)  Oral  Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg  SZ  MP NP     P14238  2  5     1

[35] Schedule 1, Part 1, after entry for Ezetimibe and rosuvastatin in the form Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) [Brand: Ezalo Composite Pack 10mg+40mg; Maximum Quantity: 2; Number of Repeats: 5]
insert:
Ezetimibe and rosuvastatin  Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)  Oral  Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg  SZ  MP NP             1  5     1
Ezetimibe and rosuvastatin  Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)  Oral  Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg  SZ  MP NP     P14238  2  5     1

[36] Schedule 1, Part 1, after entry for Ezetimibe and rosuvastatin in the form Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) [Brand: Ezalo Composite Pack 10mg+5mg; Maximum Quantity: 2; Number of Repeats: 5]
insert:
Ezetimibe and rosuvastatin  Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)  Oral  Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg  SZ  MP NP             1  5     1
Ezetimibe and rosuvastatin  Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)  Oral  Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg  SZ  MP NP     P14238  2  5     1

[37] Schedule 1, Part 1, entry for Faricimab in the form Solution for intravitreal injection 28.8 mg in 0.24 mL (120 mg per mL) [Maximum Quantity: 1; Number of Repeats: 2]
(a) insert in numerical order in the column headed "Circumstances": C13336 C13387
(b) insert in numerical order in the column headed "Circumstances": C16309 C16319
(c) insert in numerical order in the column headed "Purposes": P13336 P13387
(d) insert in numerical order in the column headed "Purposes": P16309 P16319
[38] Schedule 1, Part 1, entries for Fingolimod
substitute:
Fingolimod  Capsule 250 micrograms (as hydrochloride)  Oral  Gilenya               NV  MP NP  C16325 C16346     28  5     28
Fingolimod  Capsule 500 micrograms (as hydrochloride)  Oral  AKM Fingolimod        RW  MP NP  C16301 C16323     28  5     28
Fingolimod  Capsule 500 micrograms (as hydrochloride)  Oral  Fingolimod Sandoz     SZ  MP NP  C16301 C16323     28  5     28
Fingolimod  Capsule 500 micrograms (as hydrochloride)  Oral  Fingolimod SUN        RA  MP NP